Intellectual Property
 General IP Issues
Reform of the European Patent System
EGA Reports, Articles & Positions
EGA COMMENTS FOR THE SACEPO/EPO ANNUAL MEETING ON HOW TO IMPROVE THE EFFICIENCY OF EUROPE'S PATENT SYSTEM
• EGA Position | July 2010
HOW TO IMPROVE THE EFFICIENCY OF THE EUROPEAN PATENT SYSTEM
A presentation delivered at the STOA Conference in the European Parliament in Brussels on 17 March 2009
• Greg Perry, Director General, EGA
THE EUROPEAN PATENT COURT
The EGA welcomes the initiative of the European Commission to create a central European patent court to deal with questions of invalidity and infringement at a pan-European level and suggests some amendments to the proposal aimed at improving the text and at contributing to a more efficient system.
• EGA Position | March 2009
Better
Patents, Better Medicines: Recommendation on
How to Improve the Eurpean Patent
System
The EGA favours strong patent criteria based on the “inventive step”. Failure to enforce patent criteria (novelty, inventive step and industrial application) damages competition, and can lead to less innovation and losses for healthcare systems.
• EGA Position | October 2008
Patent-related Barriers
to Market Entry for Generic Medicines in the European Union
A review of weakness in the current European patent system and their impact on the market access of generic medicines
• EGA Report | May 2008
The European
Generic medicines Association's View of the European Patent Litigation
Agreement (EPLA)
EGA Position Paper
• December 2006
Response to the European Commission’s Questionnaire on the Patent System in Europe
EGA Position Paper
• March 2006
Counterfeiting of Medicines
a) Legislative Documents
GREEN PAPER on Combating Counterfeiting and Piracy in the Single Market
Presented by the European Commission
• Brussels, COM(98) ...
b) EGA Positions and Articles
EGA Statement on Counterfeiting and Patent Infringement in the Context of the Anti-Counterfeiting Trade Agreement (ACTA)
The EGA has major concerns that the common enforcement practices proposed by ACTA to promote strong intellectual property rights could be misused by holders of intellectual property rights against legitimate competition.
• June 2008
Key Ideas for Better Protection of Patients Against the Risk of Counterfeit Medicines
EGA Position Paper in Response to the European Commission Public Consultation in Preparation of a Legal Proposal to Combat Counterfeit Medicines for Human Use
• May 2008
Position Paper on Anti-Counterfeit Policy
In response to the European Commission’s Consultation for DG ENTR Study on Distribution Channels - Part I ‘Combating Counterfeit Medicines’
• April 2007
"Business with Certified Partners Only": Position Paper on Anti-counterfeit Policy
EGA Position Paper
• July 2006
Enforcement of Intellectual Property
a) Legislative Documents
Directive of the European Parliament and of the Council on measures and procedures to ensure the enforcement of intellectual property rights
A proposal presented by the European Commission: COM(2003) 46 final - 2003/0024 (COD)
• Brussels - 30 January 2003
b) EGA Positions and Articles
EGA POSITION on the draft Directive on criminal measures aimed a ensuring the enforcement of Intellectual Property Rights
EGA Position Paper
• May 2006
The Proposal for a Directive on the Enforcement of Intellectual Property Rights
A Preliminary EGA Position Paper.
• April 2003
The Proposal for a Directive on the Enforcement of Intellectual Property Rights
EGA Proposal for amendments to the Commission Propsal.
• June 2003
Scenario for Generic Medicine “A” under the EU Directive on Enforcement of Intellectual Property Rights
EGA asks that patents be excluded from the scope of the Directive; generic producers are not criminals!!!
EGA Reaction to the Fourtou Report
• 2004
Generics: “Dolphins Caught in the Tuna Net”
The deadly effect of the proposed IP enforcement directive on EU generic industries.
by Veronica Lowe • Published in Competition Law Insight.
• July/August 2003
|
